ATAI Life Sciences N.V (NASDAQ:ATAI) shares, rose in value on Thursday, July 10, with the stock price up by 2.63% to the previous day’s close as strong demand from buyers drove the stock to $2.73.
Actively observing the price movement in the last trading, the stock closed the session at $2.66, falling within a range of $2.53 and $2.76. The value of beta (5-year monthly) was 1.484. Referring to stock’s 52-week performance, its high was $2.98, and the low was $1.03. On the whole, ATAI has fluctuated by 19.74% over the past month.
With the market capitalization of ATAI Life Sciences N.V currently standing at about $548.05 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-14.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that ATAI’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium-term indicators have put the stock in the category of 100% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the price of ATAI currently trading nearly 14.32% and 31.26% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 64.11, while the 7-day volatility ratio is showing 8.28% which for the 30-day chart, stands at 8.82%. Furthermore, ATAI Life Sciences N.V (ATAI)’s beta value is 1.45.
A comparison of ATAI Life Sciences N.V (ATAI) with its peers suggests the former has fared considerably weaker in the market. ATAI showed an intraday change of 2.63% in last session, and over the past year, it grew by 105.26%%.
Data on historical trading for ATAI Life Sciences N.V (NASDAQ:ATAI) indicates that the trading volumes over the past 10 days have averaged 9.11 and over the past 3 months, they’ve averaged 3.34 million. According to company’s latest data on outstanding shares, there are 199.78 million shares outstanding.
Nearly 31.72% of ATAI Life Sciences N.V’s shares belong to company insiders and institutional investors own 10.04% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 10.96 million shares as on 2025-06-13, resulting in a short ratio of 3.83. According to the data, the short interest in ATAI Life Sciences N.V (ATAI) stood at 669.00 of shares outstanding as of 2025-06-13; the number of short shares registered in 2025-05-15 reached 12.79 million. The stock has risen by 114.96% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ATAI stock heading into the next quarter.
